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Helicobacter pylori infection is associated with gas-
tritis, ulcerations, and gastric adenocarcinoma. H.
pylori secretes the vacuolating cytotoxin (VacA),
a major pathogenicity factor. VacA has immunosup-
pressive effects, inhibiting interleukin-2 (IL-2) secre-
tion by interference with the T cell receptor/IL-2
signaling pathway at the level of calcineurin, the
Ca2+-calmodulin-dependent phosphatase. Here, we
show that VacA efficiently enters activated,migrating
primary human T lymphocytes by binding to the b2
(CD18) integrin receptor subunit and exploiting the
recycling of lymphocyte function-associated antigen
(LFA)-1. LFA-1-deficient Jurkat T cells were resistant
to vacuolation and IL-2 modulation, and genetic
complementation restored sensitivity to VacA. VacA
targeted human, but not murine, CD18 for cell entry,
consistent with the species-specific adaptation of
H. pylori. Furthermore, expression of human integrin
receptors (LFA-1 or Mac-1) in murine T cells resulted
in VacA-mediated cellular vacuolation. Thus,H. pylori
co-opts CD18 as a VacA receptor on human T lym-
phocytes to subvert the host immune response.
INTRODUCTION
Helicobacter pylori (Hp) persistently infects the gastric mucosa
of more than half the world’s population. Hp causes peptic ulcer
disease and is an early risk factor for gastric cancer (Suerbaum
and Michetti, 2002). The bacterium is equipped with a set of
remarkable pathogenicity factors, including up to three distinct
type IV secretion systems (T4SS) and the vacuolating cytotoxin
(VacA). The cag-pathogenicity island (cag-PAI) encodes a T4SS
involved in translocation of the cytotoxin-associated antigen
(CagA) into host cells (Odenbreit et al., 2000). Furthermore,
cag-PAI positive strains are more frequently associated with se-
vere gastric inflammation, ulceration, and an increased risk to
develop gastric cancer (Blaser et al., 1995).20 Cell Host & Microbe 3, 20–29, January 2008 ª2008 Elsevier Inc.The vacuolating cytotoxin induces cellular vacuolation in epi-
thelial cells (Cover and Blaser, 1992). VacA is produced as
a 140 kDa precursor protein and actively secreted from Hp by
a type V autotransporter mechanism (Fischer et al., 2001). The
95 kDa secreted VacA protein varies in the signal sequence
(s1a, s1b, s1c, and s2) and/or its middle region (m1 and m2) be-
tween different Hp strains (Atherton et al., 1995). In contact with
host cells, the extracellular 95 kDa acid-activated VacA forms
anion-selective channels by oligomerization of membrane-
bound monomers (Czajkowsky et al., 1999) and is subsequently
internalized into eukaryotic cells (reviewed in Cover and Blanke,
2005). Vacuole biogenesis requires the activity of the Rab7
GTPase and the V-type ATPase. VacA treatment of epithelial
monolayers in vitro also causes reduction in transepithelial resis-
tance (Papini et al., 1998).
Several lines of evidence indicate that the initial interaction of
VacA with its target cells is through (a) high affinity receptor(s)
(Massari et al., 1998), which facilitates its interaction with the
cell membrane to form the channels, which are subsequently
internalized. Kinetic and inhibition analyses suggested the pres-
ence of at least two receptors on epithelial cells, an m1-type
specific high-affinity receptor and a common VacA receptor
interacting similarly with m1 and m2 VacA via a lower affinity
(Wang et al., 2001). Three cell surface proteins have been impli-
cated so far as specific receptors for VacA. These include the
epidermal growth factor receptor (EGFR) (Seto et al., 1998) as
well as receptor-like tyrosine phosphatase (RPTP) a (Yahiro
et al., 2003) andRPTPb (Yahiro et al., 1999; Fujikawa et al., 2003).
Upon contact with T lymphocytes, VacA is able to inhibit cell
proliferation and to interfere with the T cell receptor/interleukin-
2 (IL-2) signaling pathway at the level of the Ca2+-calmodulin-
dependent phosphatase calcineurin (Gebert et al., 2003; Bon-
cristiano et al., 2003; Sundrud et al., 2004). Nuclear translocation
of Nuclear Factor of Activated T cells (NFAT), a transcription fac-
tor acting as a global regulator of immune response genes,
is abrogated, resulting in downregulation of IL-2 transcription
(Gebert et al., 2003; Boncristiano et al., 2003). Thus, it has been
suggested that VacA partially mimics the activity of the immuno-
suppressive drugs cyclosporine A or FK506 by inducing a local
immune suppression, explaining the extraordinary chronicity of
Hp infections. Despite this rather specific interference of VacA
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T Cell Receptor for VacAwith the T cell activation pathway, themolecular interactions that
would explain the VacA specificity for T cells or for leucocytes, in
general, were unclear.
In the present study, we identified the b2 (CD18) integrin sub-
unit as a leucocyte-specific receptor for m1-VacA on human
T cells. As a heterodimeric transmembrane receptor, CD18 may
combinewith different integrina subunits, such asCD11a (to pro-
duce LFA-1), CD11b (to generate Mac-1, also known as comple-
ment receptor 3, CR3), CD11c, or CD11d. An essential role of
CD18 as a VacA receptor was convincingly demonstrated by
the use of CD18-deficient human T cells and by expression of dif-
ferent combinations of humanCD18 integrin heterodimers in chi-
nese hamster ovary (CHO) cells. A direct interaction of m1-VacA
and CD18 was evident from immunoprecipitation experiments.
We also show that murine T cells are not adequately targeted
by m1-VacA, which has major implications for the widely used
Hpmouse model.
RESULTS
Inducible VacA Sensitivity of Primary
Human CD4+ T Cells
Earlier studies showed that VacA treatment of a T cell line (Jurkat
E6.1) strongly reduced IL-2 gene transcription and IL-2 secretion
(Gebert et al., 2003; Boncristiano et al., 2003; Sundrud et al.,
2004). However, VacA did not significantly alter IL-2 secretion
of human CD4+ T cells, while it diminished their proliferation
(Sundrud et al., 2004). We now observe that pretreatment of pri-
mary human CD4+ T cells with phorbol myristate acetate (PMA)
(30 min) before adding Hp P12 bacterial supernatant (m1-VacA)
or purified VacA strongly increased the sensitivity of these cells
toward VacA (Figure 1A, columns CD4/PMA). A similar albeit
lower VacA sensitivity of human CD4+ T cells was inducible by
their preactivation with a-CD3/CD28-coated polystyrene beads
(hereafter termed a-CD3/CD28-PSB) (see Figure S1 available
with this article online), but not when soluble a-CD3/CD28 anti-
bodies were used concomitantly with VacA (Figure 1A). Resting
CD4+ T cells not preactivated by PMA or a-CD3/CD28-PSB did
not respond to VacA-mediated inhibition of IL-2 secretion
(Figure 1A).
To study the binding and internalization of VacA into primary
human CD4+ T cells, VacA was purified fromHp culture superna-
tant (Cover et al., 1997) and labeled with the Alexa 488/555 dye
(VacAAlexa). Live Confocal Laser Scanning microscopy revealed
that Jurkat T cells bound acid-activated VacAAlexa on the cell sur-
face and internalized it independently from any prior PMA activa-
tion of the cells (Figure 1B). In contrast, resting CD4+ T cells also
interacted with acid-activated VacA on the surface but showed
only minimal or no VacA internalization (Figure 1C). However,
a 30 min pretreatment of CD4+ T cells with PMA resulted in bind-
ing of VacAAlexa on the cellular surface, as well as its significant
internalization into the CD4+ T cells (Figure 1C). Treatment of
PMA-activated CD4+ T cells with calpeptin, a specific inhibitor
of the Ca2+-dependent cellular protease calpain, abolished up-
take of VacAAlexa (Figure 1C). Quantification of m1-VacA uptake
based on quenching of surface associated Alexa488 fluorophore
revealed a significant VacA internalization in PMA-treated versus
nontreated CD4+ T cells (Figure 1D). Thus, the polyclonal activa-
tion of resting humanCD4+ T cells with PMAprimes these cells toVacA uptake, resulting in cellular vacuolation and inhibition of
IL-2 signaling.
Human Migrating Primary CD4+ T Cells Show
a High and Specific VacA Binding Affinity
T cells are usually highly motile in lymph node and tissue, as can
be visualized directly in a living lymph node using intravital two-
photon microscopy (Miller et al., 2003). Integrins such as aLb2
(LFA-1), interacting with intercellular adhesion molecule 1 or 2
(ICAM-1, ICAM-2) play an important role in T lymphocyte migra-
tion. Active migration of T cells mediated by the interaction of
Figure 1. VacA Sensitivity of Primary Human CD4+ T Cells
(A) Sandwich enzyme-linked immunosorbent assay (ELISA) to measure se-
creted IL-2. Jurkat T cells and primary human CD4+ T cells ± PMA pretreat-
ment were incubated with concentrated culture supernatant (ccs) of a Hp
WT strain (P12) or VacA-negative mutant strain (P12DvacA) and activated
with a-CD3/CD28-PSB as indicated. Data points represent the mean ± SEM
from five experiments.
(B and C) m1-VacAAlexa (seen as white label) was incubated with Jurkat (B) or
human CD4+ T cells (C). For activation, T cells were treated with PMA only.
Eventually, cells were treated with the calpain inhibitor calpeptin, as indicated.
(D) Quantification of VacAAlexa into CD4
+ T cells using a fluorescence quench-
ing technique (see ‘‘Quantification of VacA Internalization’’ in the Supplemental
Data). VacA uptake in nonstimulated CD4+ T cells was set to 100%. Data
points represent the mean ± SEM from four experiments. Student’s t test,
normally distributed, two-tailed. **p < 0.01, *p < 0.05, #not significant. Bars
in micrographs represent 5 mm.Cell Host & Microbe 3, 20–29, January 2008 ª2008 Elsevier Inc. 21
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T Cell Receptor for VacAactive LFA-1 with immobilized ICAM-1 can be induced in vitro by
T cell receptor (TCR) crosslinking or PMA stimulation (Smith
et al., 2003).
Following interaction with ICAM-1, activated T cells get polar-
ized, attach at the leading edge, become motile, and migrate
randomly (Hogg et al., 2004). In a mixed population of migrating
and nonmigrating human CD4+ T cells, resting T cells were la-
beled by VacAAlexa weakly but uniformly, whereas migrating
T cells (flat and extended shape) were labeled more strongly and
focally (Figure S2 andMovie S1). A high local enrichment of VacA
was visible at the trailing edge (uropod) of polarized T cells
(Figure S2 and Movie S2).
In many cell types, migration involves regulated endocytosis
and exocytosis of integrins (Hogg et al., 2004). In T cells and pri-
mary neutrophils, unengaged LFA-1 is internalized and rapidly
recycled upon chemoattractant stimulation via a clathrin-inde-
pendent, cholesterol-sensitive pathway (Fabbri et al., 2005).
Such a recycling may also be induced by PMA-mediated activa-
tion of PKC, which activates Rap1, a Ras-related GTPase mod-
ulating LFA-1 adhesive activity in T cells (Tohyama et al., 2003).
Integrin internalization involves dynamic partitioning of integrin
molecules into detergent-resistant membranes, the lipid rafts.
In migrating T cells, lipid rafts are concentrated at the uropod.
Figure 2. Colocalization of VacA with LFA-1 at the Uropod of
Primary Human Migrating T Lymphocytes
Confocal fluorescence micrographs, demonstrating ubiquitous bind-
ing of VacAAlexa at the cell surface and its eventual uptake into cellular
vesicles (arrows). (A–L) Human CD4+ T cells activated by CD3/CD28-
PSB on human ICAM-1-coated surface. Localization of CD11a or
CD18 integrin subunits on T cells was determined by aCD11a-specific
mAB (YTH81.5, AbD serotec) or CD18-specific mAB (IB4, Ancell)
(green), as indicated. VacA was directly labeled with Alexa 555
(VacAAlexa, red). The location of CD3/CD28-PSB on T cells is indicated
by blue circles (I–L). The lower panel shows high magnifications of
areas marked by red boxes (A1–L2) detailing distinct VacA or integrin
localizations and their possible colocalization.
A preferential lipid raft association has also been de-
scribed for VacA and its interaction with HeLa cells, which
was essential for VacA cytotoxicity (Schraw et al., 2002).
Blocking of calpain by the specific peptide inhibitor cal-
peptin, which interferes with integrin clustering (Hogg
et al., 2003), abolished the uptake of VacA into PMA-acti-
vated CD4+ T cells (Figures 1C and 1D). All these observa-
tions supported the hypothesis that m1-VacA might
exploit integrin recycling vesicles in migrating T cells for
its cellular uptake.
VacAAlexa Shows Colocalization with LFA-1
We first investigated whether LFA-1 might be involved in
binding or uptake of VacA into T cells. Colocalization ex-
periments were performed with CD3/CD28-PSB-acti-
vated primary human CD4+ T cells and analyzed by live
microscopy using a confocal spinning disc microscope
(Perkin Elmer). Activated CD4+ T cells (flat and extended
shape) were visualized in the phase contrast image (Fig-
ures 2A, 2E, and 2I), with Alexa 488-labeled antibodies di-
rected against integrin subunits CD11a or CD18 (green)
(Figures 2B, 2F, and 2J) and Alexa 555-labeled VacA
(red) (Figures 2C, 2G, and 2K). Most of the CD11a or CD18 label
was concentrated either at the uropod, or in the clustered T cell
receptor/CD3/CD28-PSB interaction region at the leading edge
(Figures 2B, 2F, and 2J).
Interestingly, in polarized cells, VacA preferentially localized at
the uropod (Figures 2C, 2G, and 2K andmagnifications thereof in
Figures 2C1, 2G1, and 2K1). Although partially distinct VacAAlexa
and LFA-1 localization patterns were found, defined and repro-
ducible colocalization of VacAAlexa and CD11a or CD18 was
clearly obvious at the uropod (Figures 2D, 2H, and 2L and mag-
nifications thereof in Figures 2D1, 2H1, 2L1, and 2L2). After 1 hr,
VacA was frequently found together with LFA1 in small moving
vesicles (see Figure S3A and Movie S3), whereas an intracellular
perinuclear localization of VacAAlexa within CD4
+ T cells was rou-
tinely found after 12–16 hr (Figure S3B).
LFA-1-Deficient Jurkat T Cells
Are Nonresponsive to VacA
The T cell line J-b2.7, derived from Jurkat E6.1 cells by chemical
mutagenesis, is defective in CD11a production (Weber et al.,
1997). Thus, J-b2.7 cells lack cell surface LFA-1 (Figure S4A).
As compared to Jurkat E6.1, m1-VacA-mediated vacuolation
of LFA-1-deficient J-b2.7 cells was reduced in a quantitative22 Cell Host & Microbe 3, 20–29, January 2008 ª2008 Elsevier Inc.
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T Cell Receptor for VacAneutral red vacuolation assay (Cover et al., 1992), whereas func-
tional complementation of Jurkat-b2.7 cells by transfection with
CD11a (Jurkat-b2.7/CD11a) resulted in recovery of the vacuolat-
ing sensitivity (Figure 3A). A purified s1/m2-VacA (H. pylori strain
P76) behaved similar to m1-VacA in vacuolation induction
(Figure S5), suggesting that in Jurkat T cells this particular
m2-VacA also seems to exploit the CD18 pathway. Since differ-
ent genotypes of m2-VacA exist (m2a and m2b) (Ji et al., 2002),
a general designation of a possible m2-VacA receptor awaits
a further detailed analysis of additional m2-specific cytotoxins.
To study the effect of VacA on calcineurin and IL-2 gene expres-
sion in a LFA-1-depleted cell line, Jurkat and J-b2.7 cells were
transiently transfected with a pcDNA3-based luciferase (luc)
reporter construct carrying the IL-2 gene promoter (IL-2-luc)
(Gebert et al., 2003). The cells were treated with increasing con-
centrations of purified, acid-activated m1-VacA.
In the PMA/ionomycin-activated Jurkat cell line, VacA in-
hibited IL-2-luc gene transcription already at very low concentra-
Figure 3. VacA Sensitivity of Jurkat T Cells Is Dependent on Func-
tional CD18 Integrin on Cell Surface
(A) VacA-induced cellular vacuolation in Jurkat WT cells, Jurkat-b2.7 cells de-
fective in CD18 integrin surface localization, or CD11a gene complemented
Jurkat-b2.7 cells was measured by the quantitative neutral red assay. Vacuo-
lation is presented as 3-fold induction compared to nontreated cells.
(B) Inhibition of IL-2 secretion in Jurkat T cells is dependent on CD18 integrin. A
reporter plasmid carrying the complete IL-2 promoter coupled to the luc
reporter gene (Gebert et al., 2003) was transfected into different Jurkat T cell
lines (WT, Jurkat-b2.7 defective in LFA-1 surface expression, or CD11a gene
complemented Jurkat-b2.7) and activated with PMA/ionomycin. The Luc
activity of activated nontreated control was set to 100%. Cells were treated
with purified VacA in increasing concentrations, as indicated. Student’s
t test, normally distributed, two-tailed. Data points represent the mean ± SEM
from three experiments. **p < 0.01, *p < 0.05, #not significant. NRU, neutral red
uptake; n.a., not activated; act, activated.tions (100 ng/ml) in a concentration-dependent manner (Fig-
ure 3B). The LFA-1-deficient J-b2.7 T cells showed only
a minimal reduction in IL-2 promoter activity after activation
with PMA/ionomycin, which was independent of VacA concen-
tration. A stable J-b2.7 transfectant, complemented with the
human CD11a integrin gene, reexpressed functional LFA-1 on
the surface (Figure S4A) and regained a concentration-depen-
dent VacA sensitivity in the IL-2-luc assay (Figure 3B). FK506,
an immunosuppressive drug which enters cells independently
of a receptor, inhibited IL-2-luc activity in all cell lines (Figure 3B).
Taken together, these studies provide evidence that uptake of
VacA into Jurkat T cells and the induction of acidic vacuoles and
inhibition of IL-2 gene transcription is dependent on LFA-1. A re-
sidual vacuolating activity of VacA in J-b2.7 cells indicates that
VacA might enter Jurkat T cells by (an) additional pathway(s),
independent of CD18. Such multiple entry pathways into epithe-
lial cell lines have been described for VacA before (Schraw et al.,
2002; Ricci et al., 2000).
Reconstitution of Human b2 Integrin in CHO Cells
Confers VacA Sensitivity
Our data so far suggest a functional role of LFA-1 integrins for
VacA activity in lymphocytes. To study whether LFA-1 surface
expression per se is sufficient for VacA uptake andwhich integrin
heterodimers are able to confer VacA sensitivity, we used the
chinese hamster ovary (CHO) cells, which obviously lack human
integrins and display a very low sensitivity to VacA (Schraw et al.,
2002; Ricci et al., 2000). Stably transfected CHOcells expressing
humanaLb2 (CD11a/CD18, LFA-1), aMb2 (CD11b, CD18,Mac-1),
or aXb2 (CD11c/CD18, p150, 95) transported the functional in-
tegrin heterodimers onto the surface, as determined by flow
cytometry (Figure S4B) and ICAM-1 binding assays (data not
shown). VacA-treated CD11/CD18-transfected CHO cells re-
vealed a higher number of vacuolated CHO cells, as compared
to control CHO cells (transfected with the pcDNA vector alone)
(Figure 4A).Comparisonof vacuolationby thequantitative neutral
red assay supported the microscopic data (Figure 4B). Interest-
ingly, m1-VacA-mediated cellular vacuolation correlated well
with the level of CD18 surface expression of the corresponding
transfected cells, irrespective of the particular CD18 hetero-
dimers, indicating that the surface location of CD18, rather than
a particular CD11 integrin subunit, determines VacA sensitivity.
Stable transfection of CHO cells with humanCD18without a cor-
responding human CD11 counterpart resulted in CD18 surface
detection by FACS analysis, but the transfectants did not gain
sensitivity to VacA-mediated vacuolization (data not shown).
Thus, functional human CD18 integrin heterodimers are neces-
sary and sufficient to confer VacA sensitivity and the CD18 integ-
rin subunit acts as a surface receptor for a highly efficient VacA
binding and uptake.
Role of CD18 Integrin Intracellular
Domain for VacA Sensitivity
Many functional properties of integrins depend on the integrity of
their highly conserved short cytoplasmic domains (Fabbri et al.,
1999, 2005). In order to clarify whether outside-in or inside-out
signaling of the CD18 integrin subunit is necessary for triggering
VacA-induced uptake, CHO cells stably transfected with wild-
type (aLb2; WT) or a mutant version with a complete deletionCell Host & Microbe 3, 20–29, January 2008 ª2008 Elsevier Inc. 23
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T Cell Receptor for VacAof the cytoplasmic domain of CD18 (aLb2D733) (Fabbri et al.,
1999, 2005) were compared for VacA uptake and induction of
cellular vacuolation (Figure 4B). Despite a similar surface expres-
sion level of CD11a/CD18D733 and WT LFA-1, the VacA-in-
duced vacuolation of the mutant LFA-1 was as low as in the
Figure 4. Expression of Human CD18 Integrin in CHO Cells Confers
VacA Sensitivity
(A) Chinese hamster ovary cells (CHO) transfected with the pcDNA3 vector
alone or the cloned human b2 integrin gene together with the aL (CD11a/
CD18), the aM (CD11b/CD18) the aX gene (CD11c/CD18), or the b2 integrin
gene with a deletion (no cytoplasmic tail) (CD11a/CD18D733) were cultured
overnight in the presence of Hp P12 ccs. Vacuole formation was assessed
by phase microscopy.
(B) Quantification of vacuolation by the neutral red uptake (NRU) assay. Vacu-
ole formation in CHO cells was quantitated bymonitoring the release of neutral
red dye after VacA treatment. Cells were cultured in 12-well plates in triplicate
overnight before the addition of 500 ng/ml purified VacA. Uptake of neutral red
dye into acidic vacuoles was quantitated on a microtiter plate reader, and re-
sults were corrected for differences in cell numbers. The vacuolating activity of
pcDNA3-transfected cells was set to 100%. The level of surface exposition of
the integrin heterodimers (CD18-level, relative expression) was determined by
FACS. Data points represent the mean ± SEM from three experiments.24 Cell Host & Microbe 3, 20–29, January 2008 ª2008 Elsevier Inc.pcDNA-transfected control CHO cells, suggesting that intracel-
lular signaling of the CD18 integrin subunit is essential for its
VacA receptor function.
Direct Interaction of VacA and CD18
In order to demonstrate a direct binding of VacA to theCD18 sub-
unit, VacA was biotinylated (VacA-biotin) and used in immuno-
precipitation experiments. First, the CD18 production of different
WTandmutant Tcell lines, aswell asprimary humanCD4+Tcells,
was compared in the immunoblot (Figure 5A). Whereas the hu-
man T lymphoblastoid cell line SKW3 produces CD18, its mutant
derivative SK-b2.7 is completely defective in production of CD18
Figure 5. Immonoblots Showing CD18 Expression in Different Sets
of T Cells and Immunoprecipitation to Demonstrate a Direct Interac-
tion of m1-VacA with Human CD18 Integrin Subunit
(A) Immunoblot analysis of different human WT and CD18-deficient (SK-b2.7)
or CD11a-deficient (Jurkat-b2.7) or complemented (Jurkat-b2.7/aL) T cell lines
and primary human CD4+ T cells for CD18 expression using anti-CD18 anti-
body MEM-48.
(B) Purified membranes were prepared from SKW (WT) or b2-integrin deficient
(SK-b2.7) lymphoblastoid cell lines. VacA, cholera toxin B, and transferrin were
labeled with biotin (VacA-bio, CtxB-bio, and Tf-bio, respectively) and used to
immunoprecipitate CD18 integrin. CtxB-bio and Tf-bio served as controls to
rule out a direct binding of CD18 to biotin.
(C) Purified membranes of Jurkat, human primary CD4+, or murine EL4 T cells
transfected with human LFA-1 (hLFA-1) were used for immunprecipitation, as
above. Three independent experiments have been performed. WB, immuno-
blot; IP, immunoprecipitation; strep, streptavidin.
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T Cell Receptor for VacA(Weber et al., 1997). Jurkat-b2.7 T cells produce low amounts of
CD18, which, however, does not translocate to the cell surface
due to a missing CD11a integrin subunit (Figure S4A) (Weber
et al., 1997). Biotinylated transferrin (Tf-biotin) or biotinylated
cholera toxin B subunit (CtxB-biotin), which forms oligomers
like VacA, served as controls for the immunoprecipitation. Bind-
ing and coprecipitation of CD18 with VacA-biotin was obtained
with membrane preparations from SKW3, but not from SK-b2.7
cells (Figure 5B). CD18 was also precipitated from a membrane
preparation of Jurkat T cells or primary human CD4+ T cells using
the same approach (Figure 5C). Thus, we suggest that a direct in-
teraction of VacA and CD18 is required for VacA internalization
and inhibition of IL-2 transcription.
Effect of VacA on CD4+ T Cell Adhesion to ICAM-1
We next examined the impact of VacA binding to CD18 on LFA-1
function. Human CD4+ T cells were treated with increasing con-
centrations of purified VacA (0.1–3.0 mg/ml) and their binding to
recombinant human ICAM-1 was determined. Interestingly, al-
though VacA bound to the activated T cells, it did not interfere
with the interaction of activated CD4+ T cells to ICAM-1 (Fig-
ure S6). In contrast, a CD18 blocking monoclonal antibody
(IB4) showed a concentration-dependent inhibition of T cell bind-
ing to the ICAM-1 substrate. Thus, VacA apparently does not in-
terfere with the binding activity of activated b2 integrin receptors
to their substrate, which is in accordance with the fact that a very
specific interaction of VacA takes place with the surface integrin
receptor only at the uropod. This scenario suggests a defined ac-
tivation state of the integrin to be recognized by VacA, consistent
with a single CD18 integrin species coprecipitating with VacA
(Figures 5B and 5C). As shown in the total cell lysates (Figure 5A),
SKW3, Jurkat, and primary human CD4+ T cells express diverse
subtypes of CD18, probably representing different integrin mod-
ifications (Dahms and Hart, 1985, 1986).
Resistance of Murine T Lymphocytes to s1m1-VacA
Hp is a specific pathogen of humans, but upon adaptation, the
bacteria do also colonize laboratory animals. H. pylori vacA
null mutant strains can successfully colonize the stomachs of
several animal models, including gnotobiotic piglets, mice, and
Mongolian gerbils (Eaton et al., 1997; Ogura et al., 2000; Wirth
et al., 1998; Marchetti et al., 1995; Salama et al., 2001). Hp-in-
fected mice show a mild gastric inflammation with no typical
gastroduodenal disease. We analyzed the putative interaction
of VacA and its effect on IL-2 secretion onmurine T cells by using
the lymphoblast T cell line EL4 (ATCC TIB-39), and primary
mouse spleen CD4+ T cells from BALB/c and C57BL/6 mice. In
contrast to human T cells, murine T cells did not significantly re-
spond to m1-VacA treatment, neither by vacuolation (data not
shown) nor by inhibition of IL-2 secretion (Figure 6A). Similar
data have been reported recently for primarymurine splenocytes
or CD4+ T cells (Algood et al., 2007).
A possible reason for this lack of activity might be the rather
inefficient binding of m1-VacA to murine as compared to human
T cells, as demonstrated by a quantitative flow cytometric bind-
ing assay (Figure 6K). VacAAlexa (green) associated to the uropod
(Figures 6H and 6J), but in contrast to Alexa555-labeled cholera
toxin B (CtxB) (red), VacA was never internalized bymurine CD4+
T cells, even after PMA activation (Figures 6C–6J).Humanized Murine EL4 T Cells
Murine EL4 T cells were then reconstituted with single human
CD11a, CD11b, or CD18 genes, and appropriate combinations
thereof. Clones were selected for stable expression and en-
riched for high level surface localization of the corresponding an-
tigens by FACS sorting (Figure S7A). Purifiedm1-VacA induced a
concentration-dependent increase in vacuolation in both LFA-1
and Mac-1-humanized EL4 T cells, as measured by the
Figure 6. Hp m1-VacA Fails to Inhibit IL-2 Production in Murine
T Cells Due to a Low Binding Activity and Failure of Cellular Internal-
ization
(A) To measure IL-2 secretion by ELISA, Jurkat T cells, murine EL4 T cells, and
primary murine CD4+ T cells purified from the spleen of mice (C57BL/6) were
analyzed. Cells preactivated by PMA were infected by Hp ccs, purified VacA,
or FK506 as indicated; stimulated with PMA/ionomycin; and compared with
stimulated noninfected control (100%). Data points represent the mean ±
SEM from three experiments.
(B) VacA-inducedcellular vacuolation inEL4WTor LFA-1- (clone2D9) orMac-1
(clone 3B4)-humanized EL4 T cells was measured by the quantitative neutral
red assay (NRU). Vacuolation is presented as 3-fold induction as compared
to nontreated cells. n = 6, not normally distributed, Mann-Whitney Sum U
test (SigmaSTAT), two-tailed. *p < 0.05, **p < 0.01. Data points represent the
mean ± SEM from three experiments.
(C–J) Murine CD4+ T cells activated by PMA migrating on murine ICAM-1.
CtxBAlexa (red) was readily internalized (30 min, 37
C) (E–F, I, and J), whereas
VacAAlexa (green) binds with low affinity to the uropod of migrating T cells
(H and J) and is not internalized (0–12 hr). No colocalization of VacA and
CtxB was detected on these cells. Micrographs (G)–(J) represent a higher
magnification of a single CD4+ T cell. Bar represents 5 mm.
(K) Quantification of VacAAlexa binding to unstimulated and PMA preactivated
(10 nM) murine or human CD4+ T cells by flow cytometry.Cell Host & Microbe 3, 20–29, January 2008 ª2008 Elsevier Inc. 25
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T Cell Receptor for VacAFigure 7. Working Model of the CD18-Dependent
Uptake of m1-VacA into T Cells and Modulation of the
T Cell Response
(1) VacA binds to a so far unknown probably GPI-anchored
membrane-associated protein (factor X). (2) Upon activation
of the T cell and subsequent spreading, VacA is recruited to-
gether with factor X to the uropod of the trailing edge. (2)
VacA interacts with CD18 of a defined activation state. (3)
The integrin heterodimer LFA-1 is internalized upon migration
of the T cell (or constantly in T cell lines), and VacA inserts
into the endosomal membrane forming a channel inducing
cellular vacuolation. (4) In human T cells VacA is able to
escape into the cytosol. (5) VacA might block calcineurin ac-
tivity, which results in inhibition of IL-2 transcription and
immunomodulation.quantitative neutral red assay (Figure 6B). In contrast to vacuola-
tion, no significant inhibition of IL-2 secretion of humanized EL4
T cells by m1-VacA was observed (Figure S7B and S7C), al-
though a direct binding of m1-VacA to the human CD18 subunit
expressed in murine EL4 cells (EL4 hLFA-1) was detected
(Figure 5C).
DISCUSSION
The receptor described here, the integrin receptor CD18, is
a VacA receptor specific for immune cells. Several putative re-
ceptors for VacA have been previously identified on epithelial
cells (Yahiro et al., 1999, 2003), but mostly on transformed cell
lines rather than on primary cells. CD18 is apparently not the
sole surface molecule on T cells interacting with VacA, since in
the Jurkat-b2.7 cell line VacA is still able to bind (data not shown).
However, an important function of CD18 for binding and/or up-
take of VacA into T cells is evident from CD18-defective Jurkat
T cells, as well as from genetic complementation of murine (EL4
T cells) or hamster (CHO) cell lines. Finally, a direct interaction
of VacA with human CD18 by immunoprecipitation supported
the functional and microscopic VacA/CD18 colocalization data
and identified CD18 as a receptor or coreceptor for VacA.
The Ca2+-dependent protease calpain is required for the re-
lease of integrins from the cytoskeleton, permitting their lateral
mobility in the membrane and subsequent clustering (Hogg
et al., 2003; Stewart et al., 1998). Inhibition of calpain by the spe-
cific peptide inhibitor calpeptin interferes with the internalization
of integrins and clearly blocked the uptake of VacA into PMA-ac-
tivated CD4+ T cells (Figure 1C). However, a panel of a-CD18 an-
tibodies (IB4,MEM-48,MEM-148, andMCA503) did not interfere
with VacA-mediated IL-2 inhibition in PMA-activated CD4+
T cells (data not shown), indicating that they did not interfere
with the binding site of VacA on CD18 or did not block the uptake
or internalization of CD18. Thus, in contrast to many cell lines,
uptake of VacA into primary T cells and its effects on cellular
function is definitely dependent on the presence of the CD18
receptor and its cellular internalization.
Several other prominent bacterial toxins and also viruses use
integrins for their internalization into host cells. Thus, CD11a/
CD18 has been identified as a receptor for RTX toxins, such as26 Cell Host & Microbe 3, 20–29, January 2008 ª2008 Elsevier Inc.the Escherichia coli hemolysin or the leukotoxin of the dental
pathogen Actinobacillus actinomycetemcomitans (Lally et al.,
1997). The adenylate cyclase toxin of Bordetella pertussis binds
to target cells of the immune system via CD11b/CD18 (Guer-
monprez et al., 2001) and enters the cells to shape with its enzy-
matic activity the local adaptive immune response toward toler-
ance of the pathogen (Vojtova et al., 2006).
Since CD18 is usually absent on the membrane of epithelial
cells, the route of uptake and intracellular trafficking of VacA
and its ability to escape into the cytosol and to interfere with
cytokine signaling seems to depend on its route of entry. There
might be significant differences in binding of VacA and uptake
between epithelial cells and immune cells (Gauthier et al.,
2005), as well as between T cells of murine and human origin
(see Figure S7). The unexpected functional differences between
human and murine humanized T cells in inhibition of VacA-medi-
ated IL-2 expression suggest a highly specific pathway in human
T cells for VacA internalization. Thus, differences in a late step of
VacA intoxication, beyond the vacuolation step, e.g., transloca-
tion of VacA from the vacuole into the cytosol, or interaction with
the cytosolic VacA target might be incompatible in the mouse
model. This topic is presently the subject of intensive investiga-
tions. Our data are summarized in a current model of VacA action
on T lymphocytes (Figure 7). As a final consequence, the high
species specificity of VacA seriously challenges the suitability
of the mouse model for many Hp pathogenesis studies, since
neither is the cag-T4SS stable in the mouse model (Philpott
et al., 2002), nor is there an activity of m1-VacA on IL-2 secretion
in mouse T cells (this work).
Finally, we have shown that m1-VacA enters human T lympho-
cytes via the CD18 integrin receptor. Besides its multiple activi-
ties on epithelial cells, which represent a first barrier for Hp, the
use of CD18 as a receptor qualifies VacA as an immunomodulin.
The IL-2 modulating activity of VacA, together with the recently
described inhibition of T cell proliferation byHp gamma-glutamyl
transpeptidase (Schmees et al., 2007), impressively underscores
the general immune subversion activities of Hp (Baldari et al.,
2005). Since LFA-1 is an integrin receptor present on all leuko-
cytes subsets, VacA might use it also in granulocytes, macro-
phages, dendritic cells, B cells, or NK cells. Indeed, initial exper-
iments using VacAAlexa for infection of primary human dendritic
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T Cell Receptor for VacAcells (DCs) show similar results as those for T cells. VacA prefer-
entially binds to the uropod of DCs and colocalizes with CD18,
followed by its strong intracellular accumulation in a perinuclear
localization (data not shown). Taken up by DCs, VacA might also
be transported to the local lymph node and delivered to T cells or
influence a successful DC/T cell interaction. Thus, our data indi-
cate that VacA has a great potential to immunomodulate its hu-
man host and to contribute to the chronicity of the Hp infection.
On the other hand, these resultsmay promote the design of VacA
analogs with an innovative immunosuppressive mechanism,
which may be useful in widespread pathologic conditions,
such as autoimmunity and transplantation.
EXPERIMENTAL PROCEDURES
Strains and Cell Culture
Hp strain P12 and 60190 and its isogenic mutants DvacA have been described
previously (Gebert et al., 2003). P12 and 60190 produce an s1m1-VacA. Puri-
fied s1m1-VacA from H. pylori strain 60190 has been used for all VacA ex-
periments unless indicated differently. Jurkat E6.1 T cells (ATCC TIB-152),
Jurkat-b2.7 (aL-deficient), SKW3 T cells, SK-b2.7 (b2-deficient), and murine
EL4Tcells (ATCCTIB-39)weremaintained inRPMI1640medium (GIBCO) sup-
plemented with 10% fetal bovine serum (FCS; GIBCO). CHO cells were main-
tained inNutrientMixture F12 (HAM)medium (GIBCO) supplementedwith 10%
FCS. If necessary for selection, G418 (1 mg/ml) (PAA), Hygromycin (150 mg/ml)
(PAA), or Zeocin (200 mg/ml) (Invitrogen) was added.
Preparation of Human PBLC and Isolation of Primary CD4+ T Cells
PBLC were isolated from human peripheral blood of Hp-negative donors as
described (Gebert et al., 2003). Briefly, Ficoll-Hypaque density gradient centri-
fugation using Biocoll separating solution (density 1.077 g/ml; Biochrom AG)
was applied, followed by positive selection of CD4+ T cells using the MACS
cell separation system (Miltenyi Biotec) with beads coated with anti-human
CD4 antibody. Purification was performed according to the manufacturer’s in-
structions. Cells were maintained in RPMI medium containing 10% FCS and
Gentamicin (50 mg/ml; Sigma) at 37C in a 5% CO2 atmosphere.
T Cell Stimulation
For IL-2 inhibition experiments, primary T cells (5 3 105/ml) were treated with
250 mg/ml P12 concentrated culture supernatant (ccs), P12DvacA ccs, or vary-
ing concentrations (0.025–5 mg/ml) of purified, acid-activated VacA (m1 VacA,
isolated from Hp 60190) with or without pretreatment with 20 nM PMA for the
indicated time. After 1 hour, cells were stimulated with a-CD3 (HIT3a, BD Bio-
sciences) and a-CD28 (CD28.2, BD Biosciences), either soluble or bound to
polystyrene beads for 18–22 hr. Polystyrene beads (Polysciences) were
coated with anti-human CD3 and CD28 monoclonal antibodies for CD4+
T cell activation. In short, 5 3 107 beads were resuspended in 15 ml cold
PBS (GIBCO) and incubated for 1.5 hr at 37C using 5 mg anti-CD3 and
20 mg anti-CD28. After centrifugation at 8750 g for 10 min at 4C, beads
were blocked with RPMI 10% FCS for 1 hr at room temperature. Beads were
resuspended in RPMI 10%FCS to a concentration of 13 105 beads permicro-
liter. For activation of primary lymphocytes, 1.5 beads per cell were used. IL-2
production was measured as described (Gebert et al., 2003).
Isolation of Primary Murine T Cells from Spleen
Freshly removed mouse spleens were homogenized (cell strainer, pore size
70 mm; BD Falcon) with 3 ml PBS/2 mM EDTA. Cell suspension was further
homogenized by pipetting and passing through a second cell strainer (pore
size 40 mm; BD Falcon). Petri dish was repeatedly washed with PBS/EDTA. Af-
ter two washing steps with PBS/2 mM EDTA and centrifugation (10min, 300 g,
20C), cells were resuspended in 1 ml cold PBS/2 mM EDTA/0,5%BSA and
CD4 positive T cells were isolated using theMACS cell separation system (Mil-
tenyi Biotec) according to the manufacturer’s instruction.Concentrated Culture Supernatants and Purification of Hp VacA
Concentrated culture supernatants (ccs) of Hp strains were prepared as de-
scribed (Gebert et al., 2003). For VacA purification, Hp strain 60190 was cul-
tured in Brucella broth supplemented either with 10% FCS, or with 2 g/l of
b-methyl-cyclodextrin (Sigma). VacA was purified from culture supernatant
by precipitation with a 44% saturated solution of ammonium sulfate and gel
filtration chromatography using a Sephacryl S300 16/60 column (Pharmacia
biotech). Fractions were tested for VacA by western blot and concentrated
using Amicon ultra 100 k centrifugal filter devices. Protein concentration was
determined by Bradford assay. All experiments were performed with acid-
activated VacA preparations. 0.2 (v/v) of 300 mM HCl was added to VacA
solution, incubated for 30 min at 37C and neutralized with the same volume
of 300 mM NaOH.
IL-2 ELISA
Jurkat T cells, EL4 T cells, and freshly isolated primary human and murine
T cells were preincubated with 10 nM phorbol myristate acetate (PMA; Sigma)
overnight, counted in a Neubauer chamber, and seeded at a cell density of
3 to 5 3 105 cells/ml into 48-well plates the next day. Cells were treated with
150 mg/ml of concentrated culture supernatant (ccs) or 500 ng/ml purified
VacA. Before addition to cells, purified toxin preparations were acid activated
(as described above). After 1 hour of incubation (37C, 5% CO2), cells were
stimulated with PMA (10 nM) and ionomycin (1 mM) for 18–20 hr. Cells were
removed by centrifugation and the supernatant was assayed for the presence
of IL-2 (BD OptEIA IL-2 Sets, BD Biosciences).
FACS Analysis to Determine Integrin Expression
and Surface Heterodimer Formation
For flow cytometric analysis of the expression of human integrin subunits,
monoclonal antibodies G43-25B (CD11a), ICRF44 (CD11b), B-Iy6 (CD11c),
and 6.7 (CD18) from BD Biosciences were used. For the analysis, a Coulter
Epics XL-MCL flow cytometer was used and the data were processed with
the WinMDI 2.8 software. Live cell experiments were performed with an Ultra-
View LCI spinning disk confocal system (PerkinElmer Life and Analytical Sci-
ences) fitted on a Nikon Eclipse TE300 microscope equipped with a tempera-
ture- and CO2-controllable environment chamber.
Quantification of VacA-Induced Vacuolation
EL4 or Jurkat T cells were incubated with varying concentrations of acid-acti-
vated VacA for 6 hr. NH4Cl was added to a final concentration of 1 mM and
cells were further incubated for at least 2 hr. Vacuolation was quantified by
neutral red staining (Cover et al., 1992). Therefore, cells were centrifuged,
resuspended in RPMI/10%FCS with 0.008% neutral red, and incubated for
10 min. After two washing steps with PBS/0.5%BSA, neutral red was
extracted with 70% Ethanol, 0.37% HCl and transferred into a 96-well plate
(Corning Life Sciences). Neutral red was quantified by absorption at 534 nm
(reference wavelength 405 nm) using a Tecan Sunrise microtiter plate reader.
Live Cell Imaging Microscopy
VacA was fluorescently labeled using Alexa Fluor 555/488-succinimidyl ester
(Molecular Probes). Labeling reaction was performed according to the manu-
facturer’s instructions.
Statistical Analysis
Data are presented as mean ± SEM. Differences between groups were
assessed by the paired, two-tailed Student’s t test or by the Mann-Whitney
U test for unpaired groups depending on the data set of concern (see figure
legends).
Supplemental Data
The Supplemental Data include Supplemental Experimental Procedures,
seven supplemental figures, and five supplemental movies and can be found
with this article online at http://www.cellhostandmicrobe.com/cgi/content/full/
3/1/20/DC1/.Cell Host & Microbe 3, 20–29, January 2008 ª2008 Elsevier Inc. 27
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